Effect of Fish Oil on Markers of the Metabolic Syndrome in Overweight Adolescent Boys

Effect of n-3 LCPUFAs on Weight Reduction and Metabolic Syndrome.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00929552

Acronym

TeenFisk

Enrollment

Registered

2009-06-29

Start date

2007-11-30

Completion date

2009-06-30

Last updated

2012-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

Blood pressure, Insulin sensitivity, Blood lipid profile

Brief summary

The aim of the study is to investigate if dietary fish oil has a beneficial effect on blood pressure, insulin sensitivity, blood lipid profile, body composition and metabolic rate in healthy, but slightly overweight, teenage boys. We hypothesized that the n-3 long chain polyunsaturated fatty acids from fish oil might have greater effect during growth and development, as intervention trials studying the effect of fish oil on babies have shown greater effects than in adults.

Interventions

DIETARY_SUPPLEMENTDietary oils (fish, vegetable oil)

6g pr day.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

MALE

Age

13 Years to 15 Years

Healthy volunteers

Yes

Inclusion criteria

* Weight above the 90th percentile for height and age.

Exclusion criteria

* Smoking, severe illnesses.

Design outcomes

Primary

Measure	Time frame
Markers of the metabolic syndrome. Blood pressure, insulin sensitivity, HDL-cholesterol and triacylglycerol.	Intervention period = 16 weeks

Secondary

Measure	Time frame
Body composition	16 weeks

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026